Bcl-2 was also phosphorylated at the serine 70 residue within the loop domain in the paclitaxel resistant cancer cells, which enhances Bcl-2 anti-apoptotic activity (Figure 2C) [35, 43]. Here, BCL2 is linked to cancer.